Marrocco, Ilaria
 Distribuzione geografica
Continente #
AS - Asia 809
NA - Nord America 680
EU - Europa 312
SA - Sud America 199
Continente sconosciuto - Info sul continente non disponibili 35
AF - Africa 25
AN - Antartide 1
OC - Oceania 1
Totale 2.062
Nazione #
US - Stati Uniti d'America 647
SG - Singapore 329
CN - Cina 227
BR - Brasile 165
IT - Italia 99
VN - Vietnam 76
IN - India 51
IE - Irlanda 37
FR - Francia 36
DE - Germania 35
FI - Finlandia 26
ID - Indonesia 25
KR - Corea 19
HK - Hong Kong 18
BD - Bangladesh 17
RU - Federazione Russa 17
SE - Svezia 17
AR - Argentina 16
CA - Canada 14
JP - Giappone 14
GB - Regno Unito 10
IQ - Iraq 8
NL - Olanda 7
ZA - Sudafrica 7
AT - Austria 6
DZ - Algeria 6
EC - Ecuador 6
PK - Pakistan 6
CL - Cile 5
JM - Giamaica 5
ES - Italia 4
MX - Messico 4
PL - Polonia 4
UA - Ucraina 4
AZ - Azerbaigian 3
CO - Colombia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EG - Egitto 3
SN - Senegal 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
PY - Paraguay 2
SA - Arabia Saudita 2
TW - Taiwan 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EE - Estonia 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PG - Papua Nuova Guinea 1
SV - El Salvador 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.028
Città #
Singapore 167
Ashburn 119
San Jose 84
Hefei 58
Beijing 39
Dublin 37
Milan 27
Jakarta 24
Helsinki 22
Lauterbourg 21
Pune 21
Council Bluffs 20
Ho Chi Minh City 20
Frankfurt am Main 19
Seoul 19
Hanoi 18
New York 18
Rome 18
Hyderabad 17
Hong Kong 16
Los Angeles 16
Dallas 14
Kent 14
Moscow 13
São Paulo 13
Tokyo 13
Chicago 11
Bologna 10
Phoenix 9
Santa Clara 8
Boardman 6
Dhaka 6
Nuremberg 6
Brooklyn 5
Haiphong 5
North Bergen 5
Paris 5
Rio de Janeiro 5
Baghdad 4
Belo Horizonte 4
Brescia 4
Da Nang 4
Falkenstein 4
Halle 4
Johannesburg 4
Kingston 4
Lappeenranta 4
Porto Alegre 4
Vienna 4
Atlanta 3
Baku 3
Blumenau 3
Brampton 3
Brno 3
Busto Arsizio 3
Charlotte 3
Dakar 3
Elk Grove Village 3
Juiz de Fora 3
Quito 3
San José 3
Seattle 3
Stockholm 3
Amman 2
Arese 2
Atibaia 2
Bexley 2
Blida 2
Boston 2
Bắc Ninh 2
Campinas 2
Carrollton 2
Changsha 2
Chennai 2
Chlef 2
Covington 2
Curitiba 2
Denver 2
Dubai 2
Durban 2
Edmonton 2
Erba 2
Fortaleza 2
Guayaquil 2
Hải Dương 2
Jaboatão dos Guararapes 2
Joinville 2
Kaunas 2
Lanús 2
Limeira 2
London 2
Maricá 2
Mexico City 2
Mumbai 2
Nairobi 2
Ninh Bình 2
Nova Iguaçu 2
Phủ Lý 2
Pindamonhangaba 2
Pittsburgh 2
Totale 1.108
Nome #
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib 131
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 130
Shmt2: A Stat3 signaling new player in prostate cancer energy metabolism 116
Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators 102
A combination of approved antibodies overcomes resistance of lung cancer to osimertinib by blocking bypass pathways 102
Egfr in cancer: Signaling mechanisms, drugs and acquired resistance 94
Clustering of IRE1α depends on sensing ER stress but not on its RNase activity 92
Strategies to Overcome Resistance to Osimertinib in EGFR-Mutated Lung Cancer 91
Host-dependent phenotypic resistance to EGFR tyrosine kinase inhibitors 84
TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis 82
Targeting her3, a catalytically defective receptor tyrosine kinase, prevents resistance of lung cancer to a third-generation egfr kinase inhibitor 80
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 80
An interdomain helix in IRE1α mediates the conformational change required for the sensor's activation 79
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models 77
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies 76
Cancer Immunotherapy: The Dawn of Antibody Cocktails 74
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors 72
ERp57 chaperon protein protects neuronal cells from Aβ-induced toxicity 72
Roles for growth factors and mutations in metastatic dissemination 71
Punicalagin, an active pomegranate component, is a new inhibitor of PDIA3 reductase activity 69
Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment 66
Increased intake of energy-dense diet and negative energy balance in a mouse model of chronic psychosocial defeat 63
Comparative analysis of the interaction between different flavonoids and PDIA3 58
Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score 53
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans 48
Totale 2.062
Categoria #
all - tutte 10.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.781


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202345 0 0 0 0 0 0 0 0 25 16 4 0
2023/2024226 2 44 0 34 10 43 11 3 1 9 33 36
2024/2025465 9 1 26 26 18 26 9 14 56 46 163 71
2025/20261.253 181 60 77 90 183 52 196 209 72 58 32 43
2026/202773 47 26 0 0 0 0 0 0 0 0 0 0
Totale 2.062